Therefore we speculate that the levels of plasma HSP90α might be a potential cancer-specific biomarker for diagnosis of hepatic malignancy and have the ability to distinguish between primary and secondary hepatic cancer. This evidence concerns the gene HSP90AA1 and liver cancer.